Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22210091 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: panitumumab

Study has passed its completion date and status has not been verified in more than two years.